Heart failure (HF) remains a significant cardiovascular public health concern in India, affecting an estimated 1.3 to 22.7 ...

A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

US-based Cardurion Pharmaceuticals has completed enrolment in two multi-centre, global Phase II CYCLE trials of the ...

There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.

Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk is conducting a Phase 2 study titled ‘A Research Study ...

Cardiosense says its CardioTag device is the first wearable sensor that simultaneously captures high-fidelity ECG, PPG and SCG signals ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Effects ...

TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease ...

Early symptoms like fatigue, breathlessness, swelling mimic common heart issues, causing cardiac amyloidosis to go undetected ...

"Pharmacotherapy can help people living with obesity improve overall health, not just lose weight," says Dr. Sue D. Pedersen, ...

Pharmacotherapy is an effective, evidence-based treatment for people living with obesity, as part of a long-term, ...